Evidence map›Paper›PMID 34088768›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2021

Identification of a T-bet

Saravanan Raju, Yu Xia, Bence Daniel, Kathryn E Yost, Elliot Bradshaw, Elena Tonc, Daniel J Verbaro, Kohei Kometani, Wayne M Yokoyama, Tomohiro Kurosaki and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The βNature · 2023
    Article
  5. Article
  6. Exhausted CD8Trends in immunology · 2023
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. BCL6-dependent TCF-1Immunity · 2022
    Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Saravanan RajuDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.
Yu XiaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-6397-1205
Bence DanielDepartment of Pathology, Stanford University School of Medicine, Stanford, CA.ORCID 0000-0002-2410-8767
Kathryn E YostDepartment of Pathology, Stanford University School of Medicine, Stanford, CA.
Elliot BradshawDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-5477-5309
Elena ToncDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-6604-6496
Daniel J VerbaroDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0001-5624-2488
Kohei KometaniRIKEN Center for Integrative Medical Sciences, Yokohama City, Kanagawa, Japan.
Wayne M YokoyamaDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.
Tomohiro KurosakiRIKEN Center for Integrative Medical Sciences, Yokohama City, Kanagawa, Japan.
Ansuman T SatpathyDepartment of Pathology, Stanford University School of Medicine, Stanford, CA.ORCID 0000-0002-5167-537X
Takeshi EgawaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO; egawat@wustl.edu.ORCID 0000-0001-7489-1051
Washington University in St. Louis · USRIKEN Center for Integrative Medical Sciences · JPStanford University · USParker Institute for Cancer Immunotherapy · US

Funding

NATIONAL RESEARCH SERVICE AWARD-MEDICAL SCIENTISTT32GM007200 · NIGMS · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 1985 to 2024
$59.8M
PRINCIPLES IN PULMONARY RESEARCHT32HL007317 · NHLBI · WASHINGTON UNIVERSITY · PI Steven Brody, Michael J Holtzman · 1985 to 2026
$16.1M
The transcription factor c-MYC in lymphocyte expansion and restriction of stemnessR01AI130152 · NIAID · WASHINGTON UNIVERSITY · PI Takeshi Egawa · 2017 to 2026
$4.6M
Single cell epigenomics in cancer immunity and immunotherapyK08CA230188 · NCI · STANFORD UNIVERSITY · PI SATPATHY, ANSUMAN · 2018 to 2020
$448k
THE ROLE OF TH1 CD4 T CELLS IN CONTROL OF VIRAL INFECTIONR03AI139875 · NIAID · WASHINGTON UNIVERSITY · PI EGAWA, TAKESHI · 2018 to 2019
$156k
NCI NIH HHS K08 CA230188NHLBI NIH HHS T32 HL007317NIAID NIH HHS R01 AI130152NIAID NIH HHS R03 AI139875NIGMS NIH HHS T32 GM007200
6 · The paper itself

Abstract

Persistent Ag induces a dysfunctional CD8 T cell state known as "exhaustion" characterized by PD-1 expression. Nevertheless, exhausted CD8 T cells retain functionality through continued differentiation of progenitor into effector cells. However, it remains ill-defined how CD8 T cell effector responses are sustained in situ. In this study, we show using the mouse chronic lymphocytic choriomeningitis virus infection model that CX3CR1

Indexed as

Lymphocytic ChoriomeningitisAnimalsCD8-Positive T-LymphocytesCell DifferentiationCX3C Chemokine Receptor 1Hepatitis A Virus Cellular Receptor 2Lymphocytic choriomeningitis virusMiceCX3C Chemokine Receptor 1Cx3cr1 protein, mouseHepatitis A Virus Cellular Receptor 2

Identifiers

PMID34088768
PMCPMC8642473
OpenAlexW3165838483

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.